Table 2. Demographic, clinical, and molecular data for patients with newly diagnosed anaplastic astrocytic tumours.
| Number of patients | Percentage | |
|---|---|---|
| Gender | ||
| Male | 16 | 43 |
| Female | 21 | 57 |
| Age, mean (range) | 48 (20–81) | - |
| Symptoms | ||
| Weakness | 15 | 41 |
| Sensory | 5 | 14 |
| Seizure | 16 | 43 |
| Headache | 10 | 27 |
| Vision | 3 | 8 |
| Dizziness | 3 | 8 |
| Surgery | ||
| Biopsy only | 12 | 32 |
| Partial resection | 22 | 60 |
| Gross total resection | 3 | 8 |
| Adjuvant therapy | ||
| Yes | 33 | 89 |
| Chemotherapy | 27 | 73 |
| Radiation therapy | 32 | 87 |
| Chemo + radiation | 25 | 68 |
| Outcome | ||
| Clinical progression | 23 | 62 |
| Death | 12 | 32 |
| Histological subtype | ||
| Anaplastic astrocytoma | 28 | 76 |
| Anaplastic oligoastrocytoma | 9 | 24 |
| IDH1-R132H mutation status | ||
| Positive | 18 | 49 |
| Negative | 19 | 51 |
| 1p/19q status | ||
| Loss of 1p | 1 | 3 |
| Loss of 19q | 2 | 5 |
| Loss of 1p and 19q | 0 | 0 |